Drug news
Solo Smart stentless aotrtic valve gets CE Mark- Sorin
Sorin Group, a leader in the treatment of cardiovascular diseases, announced that it has received CE (Conformit� Europ�enne) Mark approval for the Solo Smart stentless aortic valve.
Solo Smart is the evolution of the Freedom Solo valve, a truly stentless and a totally biological aortic heart valve with no synthetic material and proven outstanding hemodynamic and clinical performance since 2004.This unique bioprosthesis is designed to respect the aortic root physiology and ensure a physiological blood flow through the valve annulus. This allows the Solo Smart valve to behave like a healthy native valve, thus restoring quality of life for patients.